FGF2 and neoplasm: In addition, in an in vivo study, Fainaru et al. found depletion of DCs in a transgenic animal model that allows for their conditional ablation completely abrogated basic fibroblast growth factor-induced angiogenesis, and significantly inhibited tumor growth in these mice [43].